公开(公告)号：US20190000854A1

公开(公告)日：2019-01-03

申请号：US15969181

申请日：2018-05-02

Applicant: Hadasit Medical Research Services and Development Ltd.

Inventor： Yaron ILAN ,  Doina Cosma ROMAN ,  Michael HAYDEN ,  Einat AMIT-ROMACH

IPC: A61K31/52 ,  A61K9/28 ,  A61K45/06 ,  A61K9/00 ,  A61K9/20

CPC classification number: A61K31/52 ,  A61K9/0053 ,  A61K9/20 ,  A61K9/2846 ,  A61K45/06 ,  A61P1/16 ,  A61K2300/00

Abstract: Methods of treating patients suffering from non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), including those also suffering from type II diabetes mellitus (T2DM), with a delayed release pharmaceutical composition comprising 6-mercaptopurine are disclosed.